期刊文献+

人低分化原发性肝癌细胞系TJ3ZX-01建立及其细胞起源的初步研究 被引量:3

Establishment of A Poorly Differentiated Hepatocellular Carcinoma Cell Line TJ3ZX-01 and Research for Its Cellular Origin
下载PDF
导出
摘要 采用组织破碎直接培养法在体外建立一株人低分化原发性肝癌细胞系TJ3ZX-01,并对其生物学特征进行鉴定,利用免疫细胞化学染色与流式细胞术分析,探讨低分化原发性肝癌起源。细胞染色结果表明CK18+、CK19+、波形蛋白+、AFPlow、PCNA+、Hep-,认为该细胞系具有上皮细胞的特征,但肝细胞标记物表达较低,不具有明显的成熟肝细胞特征;利用流式细胞仪分析细胞表面标记物CD29、CD34、CD45、Thy-1(CD90)、CD133、CD49f在细胞中的表达情况,其阳性细胞的比例在传代过程中保持稳定的水平,其中少量细胞可能具有干细胞与前体细胞的性质,显示此例低分化原发性肝癌的来源为肝干细胞或前体细胞。 Cancer cell line TJ3ZX-01 were separated from poorly differentiated hepatocellular carcinomas specimen by the tissue dissection method, and their biological characteristics were identified. The cellular origin of the poorly differentiated HCC cell line was investigated with immunocytochemistry and flow cytometry analysis. Immunocytochemistry detection showed CK18+, CK19+, vimentin+, AFPlow, PCNA+ and Hep, which demonstrated the cancer cell line had the characteristics of epithelial cells but not the obvious characteristics of liver cells for the markers of the liver cell were low, The liver cell and stem cells surface markers CD29, CD34, CD45, Thy-1 (CD90), CD133 and CD49f expressed in the cell line were stable with passages. A small subset of cells in the cancer cells migth has the characters of stem cells or progenitor cells, which indicated that this hepatocellular carcinomas cell line originated from stem cells or progenitor cells.
出处 《细胞生物学杂志》 CSCD 2009年第1期101-106,共6页 Chinese Journal of Cell Biology
基金 天津市重点科技攻关专项(No.05YFSZSF02500) 天津市基金项目(No.08JCYBJC08300)资助~~
关键词 低分化 肝细胞癌 癌干细胞 细胞起源 poorly differentiated hepatocellular carcinomas cancer stem cell cellular origin
  • 相关文献

参考文献18

  • 1Reya T, Morrison S J, Clarke MF, et al. Stem cells, cancer, and cancer stem cells, Nature, 2001, 414(6859): 105-111.
  • 2Bonnet D, Dick JE. Human acute myeloid leukemia is organized as ahierarchy that originates from a primitive hematopoietic cell, Nat Med, 1997, 3(7): 730-737.
  • 3Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci USA, 2003, 100(7): 3983-3988.
  • 4Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors, Cancer Res, 2003, 63 (18): 5821-5828.
  • 5Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells, Nature, 2004, 432(7015): 396- 401.
  • 6Li C, Heidt DG, Dalerba P, et al. Identification of pancroatie cancer stem cells, Cancer Res, 2007, 67(3): 1030-1037.
  • 7Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells, Cancer Res, 2005, 65 (23): 10946-10951.
  • 8Dalerba P, Dylla S J, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells, Proc Natl Acad Sci USA, 2007, 104(24): 10158-10163.
  • 9Wu XZ, Chen D. Origin of hepatocellular carcinoma: role of stem cells, J Gastroenterol Hepatol, 2006, 21(7): 1093-1098.
  • 10Sell S. Cellular origin of hepatocellular carcinomas. Semin Cell Dev Biol, 2002, 13(6): 419-424.

共引文献104

同被引文献29

  • 1HUANG Jian National Human Genome Research Center at Shanghai-Ministry of Science and Technology to build a healthy and disease Ge-nomics Laboratory,Shanghai 201203,China.Current progress in epigenetic research for hepato-carcinomagenesis[J].Science China(Life Sciences),2009,52(1):31-42. 被引量:9
  • 2Sze-hangLAU Xin-yuanGUAN.Cytogenetic and molecular genetic alterations in hepatocellular carcinoma[J].Acta Pharmacologica Sinica,2005,26(6):659-665. 被引量:7
  • 3Couzin J.Tracing the steps of metastasis cancer's menacing ballet[J].Science,2003,299(5609):1002-006.
  • 4Yang ZF,Ho DW,Ng MN,et al.Significance of CD+90 cancer stem cells in human liver cancer[J].Cancer Cell,2008,13(2):153-166.
  • 5Li R,Younes M,Wheeler TM,et al.Expression of vascular endothelial growth factor receptor-3(VEGFR-3)in human prostate[J].Prostate,2004,58(2):193-199.
  • 6Mason JC,Yarwood H,Tarnok A,et al.Human Thy-1 is cytokine-inducible on vascular endothelial cells and is a signaling molecule regulated by protein kinase C[J].J Immunol,1996,157(2):874-883.
  • 7Shimazak IC,Sum IT,Inaba T,et al.CD+34CD+90 cells and late hematopoietic reconstitution after autologous peripheral blood stem cell transplantation[J].Leuk Lymphoma,2004,45 (4):661-668.
  • 8Cho RW,Wang X,Diehn M,et al.Isolation and molecular characte-rization of cancer stem cells in MMTV-Wnt-1 murine breast tumors[J].Stem Cells,2007,26(10):2724 -2734.
  • 9Liu G,Yuan X,Zeng Z,et al.Analysis of gene expression and chemoresistance of CD+133 cancer stem cells in glioblastoma[J].Mol Cancer Ther,2006,5(1):60-67.
  • 10Dennis JE,Esterly K,Awadallah A,et al.Clinical-scale expansion of a mixed population of bone marrow derived stem and progenitor cells for potential use in bone tissue regeneration[J].Stem Cells,2007,25(10):2575-2582.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部